Keith Westby - 01 Mar 2022 Form 4 Insider Report for IVERIC bio, Inc.

Role
SVP & COO
Signature
/s/ Todd Anderman, as attorney-in-fact for Keith Westby
Issuer symbol
N/A
Transactions as of
01 Mar 2022
Net transactions value
+$16,799
Form type
4
Filing time
02 Mar 2022, 15:50:49 UTC
Previous filing
17 Feb 2022
Next filing
18 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $16,799 +10,169 +9.4% $1.65* 118,449 01 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Stock Option (right to buy) Options Exercise $0 -10,169 -100% $0.000000* 0 01 Mar 2022 Common Stock 10,169 $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on April 9, 2012 and vested in approximately equal monthly installments through the fourth anniversary of the grant date.